Alcon C-12-006

Status: Completed

ClinicalTrials.gov Identifier: NCT01796964

Alcon C-12-006: Injections of ESBA 1008 versus Eylea in subjects with wet AMD.

Condition: Exudative Age-Related Macular Degeneration

Study Type: Interventional

Duration: 17 months

Eligibility:

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.